COPS5 and Alzheimer disease: In the current study, using APP/BIN1/COPS5 mice, we detected significant differences in IL-6 levels in 3–4-month-old mice only, that is, between saline-versus Nosustrophine-treated wild-type mice, and between saline-treated wild-type versus Nosustrophine-treated transgenic AD animals.